Investor Overview

Our Investor Information

Company Overview

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity.

Copyright West LLC. Minimum 15 minutes delayed.

Press Releases
November 13, 2019
Rhythm Pharmaceuticals to Present at Stifel 2019 Healthcare Conference
November 4, 2019
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
Upcoming Events
November 20, 2019 at 1:50 PM EST
Stifel 2019 Healthcare Conference
Investor FAQs
More FAQs are coming soon.


Delaware, November 2008


222 Berkeley Street, 12th Floor
Boston, MA 02116
Phone: 857-264-4280

CUSIP number


Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120